EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE Drug Patent Profile
✉ Email this page to a colleague
When do Efavirenz; Emtricitabine And Tenofovir Disoproxil Fumarate patents expire, and what generic alternatives are available?
Efavirenz; Emtricitabine And Tenofovir Disoproxil Fumarate is a drug marketed by Strides Pharma and is included in one NDA.
The generic ingredient in EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE is efavirenz; emtricitabine; tenofovir disoproxil fumarate. There are twenty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the efavirenz; emtricitabine; tenofovir disoproxil fumarate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE?
- What are the global sales for EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE?
- What is Average Wholesale Price for EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE?
Summary for EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 39 |
| DailyMed Link: | EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE at DailyMed |
Recent Clinical Trials for EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | N/A |
| Yu-Jay Corp. | Phase 3 |
| University of British Columbia | Phase 4 |
See all EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE clinical trials
US Patents and Regulatory Information for EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma | EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | efavirenz; emtricitabine; tenofovir disoproxil fumarate | TABLET;ORAL | 201802-001 | Oct 3, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
